Placebo-controlled, randomized, blinded, double-dummy, crossover study to investigate the attenuation of ACTH activation induced by metyrapone with a single dose of GSK561679 or alprazolam in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Verucerfont (Primary) ; Alprazolam; Metyrapone
- Indications Mental disorders
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 10 May 2008 New trial record.